Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia

Shelly R. Gunn, Mansoor S. Mohammed, Mercedes E. Gorre, Philip D. Cotter, Jaeweon Kim, David W. Bahler, Sergey N. Preobrazhensky, Russell A. Higgins, Aswani R. Bolla, Sahar H. Ismail, Daphne De Jong, Eric Eldering, Marinus H J Van Oers, Clemens H M Mellink, Michael J. Keating, Ellen J. Schlette, Lynne V. Abruzzo, Ryan S. Robetorye

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Array-based comparative genomic hybridization (array CGH) provides a powerful method for simultaneous genome-wide scanning and prognostic marker assessment in chronic lymphocytic leukemia (CLL). In the current study, commercially available bacterial artificial chromosome and oligonucleotide array CGH platforms were used to identify chromosomal alterations of prognostic significance in 174 CLL cases. Tumor genomes were initially analyzed by bacterial artificial chromosome array CGH followed by confirmation and breakpoint mapping using oligonucleotide arrays. Genomic changes involving loci currently interrogated by fluorescence in situ hybridization (FISH) panels were detected in 155 cases (89%) at expected frequencies: 13q14 loss (47%), trisomy 12 (13%), 11q loss (11%), 6q loss (7.5%), and 17p loss (4.6%). Genomic instability was the second most commonly identified alteration of prognostic significance with three or more alterations involving loci not interrogated by FISH panels identified in 37 CLL cases (21%). A subset of 48 CLL cases analyzed by six-probe FISH panels (288 total hybridizations) was concordant with array CGH results for 275 hybridizations (95.5%); 13 hybridizations (4.5%) were discordant because of clonal populations that comprised less than 30% of the sample. Array CGH is a powerful, cost-effective tool for genome-wide risk assessment in the clinical evaluation of CLL.

Original languageEnglish (US)
Pages (from-to)442-451
Number of pages10
JournalJournal of Molecular Diagnostics
Volume10
Issue number5
DOIs
StatePublished - Sep 2008
Externally publishedYes

Fingerprint

Comparative Genomic Hybridization
B-Cell Chronic Lymphocytic Leukemia
Genome
Fluorescence In Situ Hybridization
Bacterial Artificial Chromosomes
Oligonucleotide Array Sequence Analysis
Genomic Instability
Costs and Cost Analysis
Population
Neoplasms

ASJC Scopus subject areas

  • Molecular Medicine
  • Pathology and Forensic Medicine

Cite this

Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia. / Gunn, Shelly R.; Mohammed, Mansoor S.; Gorre, Mercedes E.; Cotter, Philip D.; Kim, Jaeweon; Bahler, David W.; Preobrazhensky, Sergey N.; Higgins, Russell A.; Bolla, Aswani R.; Ismail, Sahar H.; De Jong, Daphne; Eldering, Eric; Van Oers, Marinus H J; Mellink, Clemens H M; Keating, Michael J.; Schlette, Ellen J.; Abruzzo, Lynne V.; Robetorye, Ryan S.

In: Journal of Molecular Diagnostics, Vol. 10, No. 5, 09.2008, p. 442-451.

Research output: Contribution to journalArticle

Gunn, SR, Mohammed, MS, Gorre, ME, Cotter, PD, Kim, J, Bahler, DW, Preobrazhensky, SN, Higgins, RA, Bolla, AR, Ismail, SH, De Jong, D, Eldering, E, Van Oers, MHJ, Mellink, CHM, Keating, MJ, Schlette, EJ, Abruzzo, LV & Robetorye, RS 2008, 'Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia', Journal of Molecular Diagnostics, vol. 10, no. 5, pp. 442-451. https://doi.org/10.2353/jmoldx.2008.080033
Gunn, Shelly R. ; Mohammed, Mansoor S. ; Gorre, Mercedes E. ; Cotter, Philip D. ; Kim, Jaeweon ; Bahler, David W. ; Preobrazhensky, Sergey N. ; Higgins, Russell A. ; Bolla, Aswani R. ; Ismail, Sahar H. ; De Jong, Daphne ; Eldering, Eric ; Van Oers, Marinus H J ; Mellink, Clemens H M ; Keating, Michael J. ; Schlette, Ellen J. ; Abruzzo, Lynne V. ; Robetorye, Ryan S. / Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia. In: Journal of Molecular Diagnostics. 2008 ; Vol. 10, No. 5. pp. 442-451.
@article{58275194c09347e895800d9cf9f4ee2d,
title = "Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia",
abstract = "Array-based comparative genomic hybridization (array CGH) provides a powerful method for simultaneous genome-wide scanning and prognostic marker assessment in chronic lymphocytic leukemia (CLL). In the current study, commercially available bacterial artificial chromosome and oligonucleotide array CGH platforms were used to identify chromosomal alterations of prognostic significance in 174 CLL cases. Tumor genomes were initially analyzed by bacterial artificial chromosome array CGH followed by confirmation and breakpoint mapping using oligonucleotide arrays. Genomic changes involving loci currently interrogated by fluorescence in situ hybridization (FISH) panels were detected in 155 cases (89{\%}) at expected frequencies: 13q14 loss (47{\%}), trisomy 12 (13{\%}), 11q loss (11{\%}), 6q loss (7.5{\%}), and 17p loss (4.6{\%}). Genomic instability was the second most commonly identified alteration of prognostic significance with three or more alterations involving loci not interrogated by FISH panels identified in 37 CLL cases (21{\%}). A subset of 48 CLL cases analyzed by six-probe FISH panels (288 total hybridizations) was concordant with array CGH results for 275 hybridizations (95.5{\%}); 13 hybridizations (4.5{\%}) were discordant because of clonal populations that comprised less than 30{\%} of the sample. Array CGH is a powerful, cost-effective tool for genome-wide risk assessment in the clinical evaluation of CLL.",
author = "Gunn, {Shelly R.} and Mohammed, {Mansoor S.} and Gorre, {Mercedes E.} and Cotter, {Philip D.} and Jaeweon Kim and Bahler, {David W.} and Preobrazhensky, {Sergey N.} and Higgins, {Russell A.} and Bolla, {Aswani R.} and Ismail, {Sahar H.} and {De Jong}, Daphne and Eric Eldering and {Van Oers}, {Marinus H J} and Mellink, {Clemens H M} and Keating, {Michael J.} and Schlette, {Ellen J.} and Abruzzo, {Lynne V.} and Robetorye, {Ryan S.}",
year = "2008",
month = "9",
doi = "10.2353/jmoldx.2008.080033",
language = "English (US)",
volume = "10",
pages = "442--451",
journal = "Journal of Molecular Diagnostics",
issn = "1525-1578",
publisher = "Association of Molecular Pathology",
number = "5",

}

TY - JOUR

T1 - Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia

AU - Gunn, Shelly R.

AU - Mohammed, Mansoor S.

AU - Gorre, Mercedes E.

AU - Cotter, Philip D.

AU - Kim, Jaeweon

AU - Bahler, David W.

AU - Preobrazhensky, Sergey N.

AU - Higgins, Russell A.

AU - Bolla, Aswani R.

AU - Ismail, Sahar H.

AU - De Jong, Daphne

AU - Eldering, Eric

AU - Van Oers, Marinus H J

AU - Mellink, Clemens H M

AU - Keating, Michael J.

AU - Schlette, Ellen J.

AU - Abruzzo, Lynne V.

AU - Robetorye, Ryan S.

PY - 2008/9

Y1 - 2008/9

N2 - Array-based comparative genomic hybridization (array CGH) provides a powerful method for simultaneous genome-wide scanning and prognostic marker assessment in chronic lymphocytic leukemia (CLL). In the current study, commercially available bacterial artificial chromosome and oligonucleotide array CGH platforms were used to identify chromosomal alterations of prognostic significance in 174 CLL cases. Tumor genomes were initially analyzed by bacterial artificial chromosome array CGH followed by confirmation and breakpoint mapping using oligonucleotide arrays. Genomic changes involving loci currently interrogated by fluorescence in situ hybridization (FISH) panels were detected in 155 cases (89%) at expected frequencies: 13q14 loss (47%), trisomy 12 (13%), 11q loss (11%), 6q loss (7.5%), and 17p loss (4.6%). Genomic instability was the second most commonly identified alteration of prognostic significance with three or more alterations involving loci not interrogated by FISH panels identified in 37 CLL cases (21%). A subset of 48 CLL cases analyzed by six-probe FISH panels (288 total hybridizations) was concordant with array CGH results for 275 hybridizations (95.5%); 13 hybridizations (4.5%) were discordant because of clonal populations that comprised less than 30% of the sample. Array CGH is a powerful, cost-effective tool for genome-wide risk assessment in the clinical evaluation of CLL.

AB - Array-based comparative genomic hybridization (array CGH) provides a powerful method for simultaneous genome-wide scanning and prognostic marker assessment in chronic lymphocytic leukemia (CLL). In the current study, commercially available bacterial artificial chromosome and oligonucleotide array CGH platforms were used to identify chromosomal alterations of prognostic significance in 174 CLL cases. Tumor genomes were initially analyzed by bacterial artificial chromosome array CGH followed by confirmation and breakpoint mapping using oligonucleotide arrays. Genomic changes involving loci currently interrogated by fluorescence in situ hybridization (FISH) panels were detected in 155 cases (89%) at expected frequencies: 13q14 loss (47%), trisomy 12 (13%), 11q loss (11%), 6q loss (7.5%), and 17p loss (4.6%). Genomic instability was the second most commonly identified alteration of prognostic significance with three or more alterations involving loci not interrogated by FISH panels identified in 37 CLL cases (21%). A subset of 48 CLL cases analyzed by six-probe FISH panels (288 total hybridizations) was concordant with array CGH results for 275 hybridizations (95.5%); 13 hybridizations (4.5%) were discordant because of clonal populations that comprised less than 30% of the sample. Array CGH is a powerful, cost-effective tool for genome-wide risk assessment in the clinical evaluation of CLL.

UR - http://www.scopus.com/inward/record.url?scp=52249091511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52249091511&partnerID=8YFLogxK

U2 - 10.2353/jmoldx.2008.080033

DO - 10.2353/jmoldx.2008.080033

M3 - Article

C2 - 18687794

AN - SCOPUS:52249091511

VL - 10

SP - 442

EP - 451

JO - Journal of Molecular Diagnostics

JF - Journal of Molecular Diagnostics

SN - 1525-1578

IS - 5

ER -